Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alaa Hamed

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Orphanet Journal of Rare Diseases|June 26, 2021
Development of the Fabry Disease Patient-Reported Outcome (FD-PRO): a new instrument to measure the symptoms and impacts of Fabry DiseaseAlaa Hamed, Pronabesh DasMahapatra, Nicole Lyn, et al.
Hematology (Amsterdam, Netherlands)|October 21, 2016
Gaucher disease epidemiology and natural history: a comprehensive review of the literatureLuba Nalysnyk, Philip Rotella, Jason C Simeone, et al.
International Journal of Technology Assessment in Health Care|December 27, 2017
PATIENT-CENTERED DECISION MAKING: LESSONS FROM MULTI-CRITERIA DECISION ANALYSIS FOR QUANTIFYING PATIENT PREFERENCESKevin Marsh, J Jaime Caro, Erica Zaiser, et al.
BMC Complementary Medicine and Therapies|October 27, 2023
Caffeine-folic acid-loaded-chitosan nanoparticles combined with methotrexate as a novel HepG2 immunotherapy targeting adenosine A2A receptor downstream cascadeAlaa Hamed, Doaa Ghareeb, Tarek M Mohamed, et al.
Bioorganic Chemistry|May 2, 2024
Molecular docking approach for the design and synthesis of new pyrazolopyrimidine analogs of roscovitine as potential CDK2 inhibitors endowed with pronounced anticancer activityOla Alaa Hamed, Nehad Abou-Elmagd El-Sayed, Walaa R Mahmoud, et al.
Orphanet Journal of Rare Diseases|February 22, 2017
A new framework for evaluating the health impacts of treatment for Gaucher disease type 1Michael L Ganz, Sean Stern, Alex Ward, et al.
Orphanet Journal of Rare Diseases|April 22, 2024
The value of knowing: preferences for genetic testing to diagnose rare muscle diseasesCarol Mansfield, Marco Boeri, Josh Coulter, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|October 29, 2021
Assessment of the Anti-Cancer Efficiency of Silver Moringa oleifera Leaves Nano-extract against Colon Cancer Induced Chemically in RatsWael Mahmoud Aboulthana, Wafaa Ghoneim Shousha, Ehab Abdel-Raouf Essawy, et al.
Journal of Neurology|July 4, 2016
Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysisBenedikt Schoser, Andrew Stewart, Steve Kanters, et al.
Molecular Genetics and Metabolism Reports|December 13, 2021
Fabry Disease Patient-Reported Outcome (FD-PRO) demonstrates robust measurement properties for assessing symptom severity in Fabry diseaseAlaa Hamed, Pronabesh DasMahapatra, Nicole Lyn, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Orphanet Journal of Rare Diseases|June 26, 2021
Development of the Fabry Disease Patient-Reported Outcome (FD-PRO): a new instrument to measure the symptoms and impacts of Fabry DiseaseAlaa Hamed, Pronabesh DasMahapatra, Nicole Lyn, et al.
Hematology (Amsterdam, Netherlands)|October 21, 2016
Gaucher disease epidemiology and natural history: a comprehensive review of the literatureLuba Nalysnyk, Philip Rotella, Jason C Simeone, et al.
International Journal of Technology Assessment in Health Care|December 27, 2017
PATIENT-CENTERED DECISION MAKING: LESSONS FROM MULTI-CRITERIA DECISION ANALYSIS FOR QUANTIFYING PATIENT PREFERENCESKevin Marsh, J Jaime Caro, Erica Zaiser, et al.
BMC Complementary Medicine and Therapies|October 27, 2023
Caffeine-folic acid-loaded-chitosan nanoparticles combined with methotrexate as a novel HepG2 immunotherapy targeting adenosine A2A receptor downstream cascadeAlaa Hamed, Doaa Ghareeb, Tarek M Mohamed, et al.
Bioorganic Chemistry|May 2, 2024
Molecular docking approach for the design and synthesis of new pyrazolopyrimidine analogs of roscovitine as potential CDK2 inhibitors endowed with pronounced anticancer activityOla Alaa Hamed, Nehad Abou-Elmagd El-Sayed, Walaa R Mahmoud, et al.
Orphanet Journal of Rare Diseases|February 22, 2017
A new framework for evaluating the health impacts of treatment for Gaucher disease type 1Michael L Ganz, Sean Stern, Alex Ward, et al.
Orphanet Journal of Rare Diseases|April 22, 2024
The value of knowing: preferences for genetic testing to diagnose rare muscle diseasesCarol Mansfield, Marco Boeri, Josh Coulter, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|October 29, 2021
Assessment of the Anti-Cancer Efficiency of Silver Moringa oleifera Leaves Nano-extract against Colon Cancer Induced Chemically in RatsWael Mahmoud Aboulthana, Wafaa Ghoneim Shousha, Ehab Abdel-Raouf Essawy, et al.
Journal of Neurology|July 4, 2016
Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysisBenedikt Schoser, Andrew Stewart, Steve Kanters, et al.
Molecular Genetics and Metabolism Reports|December 13, 2021
Fabry Disease Patient-Reported Outcome (FD-PRO) demonstrates robust measurement properties for assessing symptom severity in Fabry diseaseAlaa Hamed, Pronabesh DasMahapatra, Nicole Lyn, et al.
Pageof 8